Smithkline Beckman Corp genetically engineer hepatitis B vaccine receive regulatory approval marketing Switzerland Luxembourg. The vaccine call Engerix-B approve country include Belgium Hong Kong. Smithkline currently consider marketing avenue United States. Merck Co MRK> genetically engineer vaccine market foreign market accord industry sources. Reuter 